Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 13.20B | 13.47B | 12.65B | 11.53B | 11.19B | 10.70B |
| Cost of revenue | 7.26B | 8.11B | 7.61B | 6.94B | 6.76B | 6.49B |
| Research and development | 951M | 862M | 840M | 815M | 774M | 760M |
| Selling, general and administrative | 798M | 1.18B | 669M | 657M | 630M | 686M |
| Operating expenses | 11.28B | 12.35B | 11.20B | 10.31B | 10.13B | 9.90B |
| Operating income | 1.92B | 1.11B | 1.45B | 1.23B | 1.06B | 796M |
| Pre-tax income | 496M | 2.62B | 1.50B | 1.39B | 2.77B | 1.08B |
| Income tax | 194M | −4.05B | 142M | −402M | 158M | 57M |
| Net income | 263M | 6.63B | 1.36B | 1.78B | 2.61B | 1.02B |
| Earnings per share | 0.13 | 3.18 | 0.65 | 0.85 | 1.24 | 0.49 |
| Earnings per share, diluted | 0.13 | 3.11 | 0.63 | 0.83 | 1.20 | 0.47 |
| Weighted average shares | 2.05B | 2.08B | 2.09B | 2.09B | 2.10B | 2.09B |
| Weighted average shares, diluted | 2.07B | 2.12B | 2.13B | 2.12B | 2.15B | 2.15B |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.56B | 7.11B | 8.43B | 6.44B | 5.13B | 5.89B | 6.15B | 4.50B |
| Short-term investments | 533M | 528M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.35B | — | — | 2.32B | — | — |
| Depreciation and amortisation | 184M | 188M | 175M | 171M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 654M |
| 932M |
| 894M |
| 1.08B |
| 2.91B |
| 1.80B |
| Receivables | 3.90B | 3.83B | 3.77B | 3.77B | 3.49B | 3.33B | 3.72B | 3.78B |
| Current assets | 12.82B | 13.99B | 15.14B | 14.11B | 12.35B | 12.25B | 15.33B | 12.48B |
| Property, plant and equipment | — | — | — | — | — | — | 1.98B | 2.03B |
| Goodwill | 8.92B | 8.93B | 8.92B | 8.91B | 8.07B | 8.07B | 8.09B | 8.08B |
| Total assets | 59.89B | 61.80B | 63.34B | 55.98B | 52.82B | 51.24B | 47.12B | 41.51B |
| Current liabilities | 11.99B | 12.32B | 13.12B | 12.69B | 12.11B | 11.48B | 10.84B | 10.32B |
| Long-term debt | 10.51B | 10.52B | 10.62B | 9.58B | 8.35B | 8.35B | 10.99B | 9.45B |
| Total liabilities | 34.07B | 33.72B | 34.19B | 32.35B | 29.92B | 28.77B | 30.58B | 27.73B |
| Equity | 24.75B | 27.04B | 28.13B | 23.45B | 22.81B | 21.56B | 15.59B | 13.15B |
| Shares outstanding | 2.04B | 2.07B | 2.08B | 2.09B | 2.09B | 2.11B | 2.10B | 2.10B |
| Shares issued | 2.04B | 2.07B | 2.08B | 2.09B | 2.09B | 2.11B | 2.10B | 2.10B |
| 179M |
| 173M |
| Share-based compensation | 473M | — | — | 435M | — | — |
| Capital expenditure | 65M | — | — | 74M | — | — |
| Investing cash flow | −773M | — | — | −542M | — | — |
| Share buybacks | 3.01B | — | — | 1.79B | — | — |
| Financing cash flow | −3.09B | — | — | −1.86B | — | — |